Table 6.
Correlation between SCCA-IgM serum levels and age, some laboratory data in addition to some clinicopathologic findings within HCC group
| Group III | SCCA-IgM | |
|---|---|---|
| r | P-values | |
| Age (years) | 0.135 | 0.351 |
| WBCs (×103/μL) | 0.047 | 0.748 |
| Hb (g/dL) | –0.450 | 0.755 |
| Platelets (×103/μL) | –0.222 | 0.121 |
| ALT (U/L) | 0.194 | 0.177 |
| AST (U/L) | 0.242 | 0.091 |
| Total bilirubin (mg/dL) | –0.009 | 0.951 |
| Direct bilirubin (mg/dL) | –0.031 | 0.831 |
| ALB (g/dL) | –0.023 | 0.370 |
| INR | 0.067 | 0.642 |
| Tumor sizea | 0.143 | 0.083 |
| PVTa | 0.017 | 0.111 |
Notes:
a
Pearson’s correlation coefficient
b
Spearman’s correlation coefficient. r=0.75–1 (strong correlation), r=0.5–0.74 (moderate correlation), r=0.25–0.49 (fair correlation), and r=0.1–0.24 (weak correlation).
Abbreviations: ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Hb, hemoglobin; HCC, hepatocellular carcinoma; INR, international normalized ratio; PVT, portal vein thrombosis; SCCA-IgM, squamous cell carcinoma antigen-IgM; WBC, white blood cell.